Yanis Boumber

Associate Professor, Medicine, Hematology Oncology Division

Emailyanis.boumber@northwestern.edu

Source: Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education/Academic qualification

Cancer Biology, PhD, University of Texas, MD Anderson Cancer Center

… → 2005

Medicine, MD, Russian State Medical University

… → 1999

Fingerprint

Dive into the research topics where Yanis Boumber is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

4 Active

Targeting Musashi-2 (MSI2) regulation of VEGFR2/VEGF-A in lung cancer
Boumber, Y.
National Cancer Institute
4/1/20 → 3/31/23
Project: Research project
Prot #Ad-p53-002: A Phase 2, Multi-Center, Open Label Study to Evaluate Efficacy and Safety of Adenoviral p53 (Ad-p53) in Combination with Immune Checkpoint Inhibitor Therapy in Patients with Progression or Recurrence of Head and Neck Squamous Cell Carcin
Boumber, Y.
MultiVir Inc.
11/22/19 → 11/22/22
Project: Research project
Prot #C-145-03: A Phase 2, Multicenter Study to Evaluate the Efficacy and Safety of Autologous Tumor Infiltrating Lymphocytes (LN-145) for the Treatment of Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Boumber, Y.
Chiltern International, Inc., Iovance Biotherapeutics, Inc.
2/23/18 → 2/23/23
Project: Research project
Prot #MK-3475-122: A Two-Arm, Open-label, Randomized Phase II Study of Pembrolizumab (MK-3475) Monotherapy Versus Standard Chemotherapy in Platinum Pre-treated, Recurrent or Metastatic Nasopharyngeal Cancer (NPC) (Keynote-122)
Boumber, Y.
Merck Sharp & Dohme Corporation
1/26/17 → 1/31/22
Project: Research project

1632 Citations
25 Article
8 Review article
2 Letter
2 Short survey

Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents
Gusakov, E. A., Topchu, I. A., Mazitova, A. M., Dorogan, I. V., Bulatov, E. R., Serebriiskii, I. G., Abramova, Z. I., Tupaeva, I. O., Demidov, O. P., Toan, D. N., Lam, T. D., Bang, D. N., Boumber, Y. A., Sayapin, Y. A. & Minkin, V. I., Jan 22 2021, In: RSC Advances. 11, 8, p. 4555-4571 17 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
Topchu, I., Karnaukhov, N., Mazitova, A., Yugai, V., Voloshin, M., Tikhomirova, M., Kit, O., Frantsiyants, E., Kharin, L., Airapetova, T., Ratner, E., Sabirov, A., Abramova, Z., Serebriiskii, I., Boumber, Y. & Deneka, A., Mar 2021, In: Journal of Thoracic Disease. 13, 3, p. 1370-1379 10 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
Makhov, P., Bychkov, I., Faezov, B., Deneka, A., Kudinov, A., Nicolas, E., Brebion, R., Avril, E., Cai, K. Q., Kharin, L. V., Voloshin, M., Frantsiyants, E., Karnaukhov, N., Kit, O. I., Topchu, I., Fazliyeva, R., Nikonova, A. S., Serebriiskii, I. G., Borghaei, H., Edelman, M. & 3 others, Dulaimi, E., Golemis, E. A. & Boumber, Y., Mar 2021, In: Oncogenesis. 10, 3, 29.
Research output: Contribution to journal › Article › peer-review

Open Access
Biomarkers for immune checkpoint inhibition in non–small cell lung cancer (NSCLC)
Bodor, J. N., Boumber, Y. & Borghaei, H., Jan 15 2020, In: Cancer. 126, 2, p. 260-270 11 p.
Research output: Contribution to journal › Review article › peer-review
29 Scopus citations
CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma
Makhov, P., Sohn, J. A., Serebriiskii, I. G., Fazliyeva, R., Khazak, V., Boumber, Y., Uzzo, R. G. & Kolenko, V. M., Dec 8 2020, In: British Journal of Cancer. 123, 12, p. 1749-1756 8 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations